Skip to main content
Default Image

Removing the Profit From Our Pills: The Case for a Public Pharma System

Any American who has paid the price of a patent-protected medicine knows the core flaw in the U.S. prescription drug system: our elected leaders have handed over control to profit-hungry corporations. And for-profit corporations gonna for-profit, as the kids would say. That is especially true when the corporations are gifted with long-term monopolies on life-essential medicines, which gives them the leverage to set take-it-or-leave it prices that net billions in revenue extracted from all of us. It doesn’t have to be this way. That is the message of an exciting new report, “Medicine for All: The Case for a Public Option in the Pharmaceutical Industry,” by Dana Brown, director of the Next System Project of the organization Democracy Collaborative

Publication date: 2019-09-17
Parent publication: Common Dreams
Publication URL: https://www.commondreams.org/views/2019/09/18/removing-profit-our-pills-case-public-pharma-system

More related work

Medicine Cost

Americans deserve publicly owned generic drugs

Bold policies could have saved America’s largest generic drug plant, but it’s never too late to start putting communities first.

read more
Illustration courtesy of United Nations

All health is public health: Busting the myths of choice and commodity

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. But the COVID-19

read more
Neil McInroy (Source: Coop News)

Neil McInroy joins TDC to advise stepped-up community wealth building program

The former CEO of a leading UK economic think tank will be central in helping build capacity to offer powerful new technical assistance to cities and local authorities pursuing community wealth building strategies.

read more